Awarded contractNeg Wo CallSuppliesSpain
Suministro estimado del medicamento de uso humano que incluye en su composición NIRSEVIMAB como principio activo frente al virus respiratorio sincitial (VRS) para el programa de vacunaciones e inmunizaciones de Castilla y León.
1 supplier awarded•1 lot awarded•€2.72M awarded
Buyer: Consejería de Sanidad de la Junta de Castilla y León / Valladolid, Spain
Published Dec 13, 2023Awarded Nov 08, 2023
Vaccines
Awarded value
€2.72M
Estimated value
€2.72M
Awarded at 100% of estimated value
Award date
Nov 08, 2023
Winners
1
Lots awarded
1
Award values
Notice total
€2.72M
Sum of lot awards
€2.83M
TED notice total and lot-level values do not exactly match.
Winners
Sanofi Aventis, S.A.
1 lotBarcelona, ESP
€2.8M This contract
28 award notices•33 awarded lots•€77.53M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0000 | Sanofi Aventis, S.A. | €2.8M | Vaccines (33651600) |